Company
Headquarters: Copenhagen, Denmark
Employees: 4
CEO: Dr. Claus Bo Søndergaard Svendsen
$13.8 Million
USD as of Feb. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$329.83 B |
![]() |
$88.79 B |
![]() |
$85.00 B |
Marinomed Biotech AG | $84.73 B |
![]() |
$78.88 B |
Company | Market Cap (USD) |
---|---|
![]() |
$428.70 B |
![]() |
$417.05 B |
![]() |
$412.24 B |
![]() |
$329.83 B |
![]() |
$275.82 B |
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Forward Pharma A/S has the following listings and related stock indices.
Stock: NASDAQ: FWP wb_incandescent
Stock: FSX: 1FPB wb_incandescent